Emergency cardiac care is an interesting challenge for digital health but it has a lot of potential if it can bring together the public and the healthcare system to create app, predictive models, and more to be able to detect stroke and acute myocardial infarction earlier, explained John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.
Emergency cardiac care is an interesting challenge for digital health but it has a lot of potential if it can bring together the public and the healthcare system to create app, predictive models, and more to be able to detect stroke and acute myocardial infarction earlier, explained John Rumsfeld, MD, PhD, chief innovation officer at the American College of Cardiology.
Transcript
What benefits are there from utilizing digital health in cases of emergency care in cardiology?
I think emergency care in cardiology is a particularly interesting problem for digital health, and here's why. When we think about other technologies in healthcare, they are often delivered currently in an office or in the hospital, and that's great. Where we have great technology, that's fantastic.
When you're talking about emergency cardiac care, you're immediately talking about early detection of the problem or predicting the problem of, say, sudden cardiac death, heart attack, or stroke. Early detection, early symptom reporting by patients or noticing if there's a cardiac arrest, early treatment—whether it's CPR or calling emergency servives or activating emregency medical services. Early diagnosis of heart attack or stroke, and then plugging them into the system.
So, in some ways, emergency cardiac care is a really interesting model, because you have to take the public, people in the public, and the healthcare system, and bring them together. And digital health, actually, should be the link between those 2 things. So for example, everything from apps to predictive models to sensors might, in the future—and I emphasize "might"—be the link between how we have earlier detectino of the risk of sudden cardiac death, the earlier detection of acute myocardial infarction, earlier detection of stroke, but then link it into the system.
There are already some apps, and there are already some tools for this, and there's frankly a lot of hype. A lot of, "wow, this is amazing. Artificial intelligence is going to predict who is going to have a stroke or heart attack." Most of that is unproven. We're still at the beginning, where we need a lot more evidence on using these digital health tools to improve that so-called chain of survival. And I think we need some serious evidence that they work or do what they say. But I"m hopeful that if clinicians and patients are working with the tech companies, we could actually design these to solve the problems we need of earlier detection and earlier activation of treatment.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More